Consortium for Clinical Metagenomics in Infectious Diseases (CCMID)
This is a temporary website for the CCMID - full website to launch mid-2024
Consortium for Clinical Metagenomics in Infectious Diseases (CCMID)
Consortium for Clinical Metagenomics in Infectious Diseases (CCMID)
Consortium for Clinical Metagenomics in Infectious Diseases (CCMID)
The CCMID is a
collaborative group of microbiologists, scientists, physicians, and industry partners working to facilitate implementation of next- generation sequencing (NGS) approaches for infectious disease diagnostics. The CCMID engages stakeholders at multiple levels of care via patient-centered, value-focused projects, education, and research.
Proposed in a Journal of Clinical Microbiology editorial (link below) and established in October 2022, the CCMID meets monthly on a virtual platform to discuss needs in this field and opportunities for advancement that leverages the combined expertise of consortium participants.
The CCMID addresses current barriers to use of metagenomics and NGS approaches for infectious disease diagnostics with the primary goal of advancing the field as a whole. Efforts focus on field need assessments / gap analyses, education, best-use recommendations / guideline development, methodology advancement, and ultimately clinical trials.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.